I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 18 studies | 45% ± 22% | |
| endothelial cell | 14 studies | 29% ± 12% | |
| oligodendrocyte precursor cell | 10 studies | 35% ± 15% | |
| GABAergic neuron | 9 studies | 47% ± 23% | |
| glutamatergic neuron | 9 studies | 48% ± 26% | |
| microglial cell | 9 studies | 23% ± 7% | |
| mast cell | 9 studies | 24% ± 6% | |
| oligodendrocyte | 9 studies | 26% ± 9% | |
| macrophage | 7 studies | 27% ± 6% | |
| dendritic cell | 7 studies | 19% ± 3% | |
| interneuron | 6 studies | 47% ± 24% | |
| fibroblast | 6 studies | 30% ± 7% | |
| neuron | 5 studies | 31% ± 12% | |
| adipocyte | 5 studies | 21% ± 6% | |
| ciliated cell | 5 studies | 25% ± 7% | |
| Mueller cell | 5 studies | 41% ± 11% | |
| endothelial cell of lymphatic vessel | 5 studies | 25% ± 7% | |
| granule cell | 4 studies | 28% ± 13% | |
| epithelial cell | 4 studies | 43% ± 22% | |
| cardiac muscle cell | 4 studies | 29% ± 1% | |
| retina horizontal cell | 4 studies | 20% ± 6% | |
| retinal rod cell | 4 studies | 18% ± 4% | |
| T cell | 4 studies | 19% ± 3% | |
| pericyte | 4 studies | 21% ± 3% | |
| smooth muscle cell | 4 studies | 19% ± 2% | |
| type I pneumocyte | 4 studies | 21% ± 6% | |
| basal cell | 4 studies | 38% ± 25% | |
| GABAergic interneuron | 3 studies | 33% ± 2% | |
| amacrine cell | 3 studies | 18% ± 3% | |
| glycinergic amacrine cell | 3 studies | 20% ± 3% | |
| myeloid cell | 3 studies | 23% ± 3% | |
| hepatocyte | 3 studies | 65% ± 18% | |
| non-classical monocyte | 3 studies | 19% ± 3% | |
| abnormal cell | 3 studies | 24% ± 8% | |
| neural progenitor cell | 3 studies | 28% ± 9% | |
| ependymal cell | 3 studies | 39% ± 20% | |
| alveolar macrophage | 3 studies | 28% ± 8% | |
| club cell | 3 studies | 25% ± 9% | |
| monocyte | 3 studies | 29% ± 2% | |
| respiratory goblet cell | 3 studies | 27% ± 13% | |
| type II pneumocyte | 3 studies | 19% ± 4% | |
| lymphocyte | 3 studies | 28% ± 7% | |
| transit amplifying cell | 3 studies | 40% ± 34% |
